An Everett-based lab operator was sentenced to prison for a $1.17M Medicare fraud scheme involving fraudulent billing for unperformed COVID-19 and respiratory tests. The case underscores ongoing regulatory challenges.

The FDA has approved Lumipulse, the first blood test for Alzheimer's diagnosis in symptomatic older adults, enabling less invasive detection of amyloid plaques and supporting earlier, accurate diagnosis and treatment options.